Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy

Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy

Background: Androgen deprivation therapy (ADT) is a mainstay of prostate cancer in both adjuvant and palliative settings. Since androgens are crucial for functional status and psychological functions, we evaluated whether blood testosterone, androstenedione, or DHEA concentrations were associated wi...

Full description

Bibliographic Details
Main Authors: Mayra Alejandra Mafla-España, María Dolores Torregrosa, Manel Beamud-Cortés, Lorena Bermell-Marco, José Rubio-Briones, Omar Cauli
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomolecules
Subjects:
metastatic prostate cancer
localised prostate cancer
frailty syndrome
geriatric assessment
LHRH analogues
androstenedione
Online Access:https://www.mdpi.com/2218-273X/13/11/1642

Internet

https://www.mdpi.com/2218-273X/13/11/1642

Similar Items